Introduction: In the realm of oncology, the quest for early detection methods has been relentless, with researchers continually seeking innovative approaches to combat cancer. Among…
Tag: jak-2
JAK2 mutations are genetic alterations commonly associated with myeloproliferative neoplasms (MPNs), a group of blood disorders characterized by abnormal production of blood cells. The identification of mutations such as JAK2 V617F plays a crucial role in supporting diagnosis, disease classification, and patient management.
Advanced molecular diagnostic technologies, including real-time PCR and genomic testing, enable sensitive and accurate detection of JAK2 mutations. Genes2Me provides innovative molecular diagnostic solutions designed to support laboratories and healthcare professionals with reliable oncology and hematology testing workflows. The JAK2-related articles available in this section provide insights into disease mechanisms, molecular testing approaches, and recent advancements in precision medicine.